Thermo Fisher Scientific has expanded its Invitrogen TrueEdit tool kit. The portfolio now includes the Invitrogen TrueCut Cas9 Protein v2, a recombinant Streptococcus pyogenes Cas9 protein for genome editing with CRISPR technology. This CRISPR-Cas9 protein is designed to deliver consistently high editing efficiency in all cell lines including standard, immune, primary, and stem.
In addition, the firm's new product line of ready-to-transfect Invitrogen TrueGuide Synthetic gRNAs offers researchers a range of selections, from economical options for routine editing tasks to high-performance choices for editing in challenging cell types such as primary cells, immune cells, and stem cells. Thermo Fisher also offers predesigned synthetic gRNAs for the entire human and mouse genome, selected for maximum knockout efficiency and specificity.